Division of Clinical Pharmacology, Department of Medicine, The University of Western Ontario, London, ON, Canada.
Hepatology. 2011 Aug;54(2):644-54. doi: 10.1002/hep.24391. Epub 2011 Jun 26.
The role of organic anion transporting polypeptides (OATPs), particularly the members of OATP1B subfamily, in hepatocellular handling of endogenous and exogenous compounds is an important and emerging area of research. Using a mouse model lacking Slco1b2, the murine ortholog of the OATP1B subfamily, we have demonstrated previously that genetic ablation causes reduced hepatic clearance capacity for substrates. In this study, we focused on the physiological function of the hepatic OATP1B transporters. First, we studied the influence of the Oatp1b2 deletion on bile acid (BA) metabolism, showing that lack of the transporter results in a significantly reduced expression of Cyp7a1, the key enzyme of BA synthesis, resulting in elevated cholesterol levels after high dietary fat challenge. Furthermore, Slco1b2-/- mice exhibited delayed clearance after oral glucose challenge resulting from reduced hepatic glucose uptake. In addition to increased hepatic glycogen content, Slco1b2-/- mice exhibited reduced glucose output after pyruvate challenge. This is in accordance with reduced hepatic expression of phosphoenolpyruvate carboxykinase (PEPCK) in knockout mice. We show that this phenotype is due to the loss of liver-specific Oatp1b2-mediated hepatocellular thyroid hormone entry, which then leads to reduced transcriptional activation of target genes of hepatic thyroid hormone receptor (TR), including Cyp7a1 and Pepck but also Dio1 and Glut2. Importantly, we assessed human relevance using a cohort of archived human livers in which OATP1B1 expression was noted to be highly associated with TR target genes, especially for glucose facilitating transporter 2 (GLUT2). Furthermore, GLUT2 expression was significantly decreased in livers harboring a common genetic polymorphism in SLCO1B1.
Our findings reveal that OATP1B-mediated hepatic thyroid hormone entry is a key determinant of cholesterol and glucose homeostasis.
有机阴离子转运多肽(OATPs),特别是 OATP1B 亚家族成员,在肝细胞处理内源性和外源性化合物方面的作用是一个重要的新兴研究领域。我们之前使用缺乏 Slco1b2 的小鼠模型(OATP1B 亚家族的鼠同源物)证明,遗传缺失会导致底物的肝清除能力降低。在这项研究中,我们专注于肝 OATP1B 转运体的生理功能。首先,我们研究了 Oatp1b2 缺失对胆汁酸(BA)代谢的影响,结果表明,该转运体的缺乏导致 BA 合成的关键酶 Cyp7a1 的表达显著降低,导致高膳食脂肪挑战后胆固醇水平升高。此外,Slco1b2-/- 小鼠在口服葡萄糖挑战后的清除速度较慢,这是由于肝葡萄糖摄取减少所致。除了肝糖原含量增加外,Slco1b2-/- 小鼠在丙酮酸挑战后的葡萄糖输出减少。这与敲除小鼠中磷酸烯醇丙酮酸羧激酶(PEPCK)的肝表达减少一致。我们表明,这种表型是由于失去了肝特异性 Oatp1b2 介导的甲状腺激素进入肝细胞,从而导致肝甲状腺激素受体(TR)的靶基因转录激活减少,包括 Cyp7a1 和 Pepck,但也包括 Dio1 和 Glut2。重要的是,我们使用一组存档的人类肝脏评估了人类相关性,其中 OATP1B1 的表达与 TR 靶基因高度相关,特别是葡萄糖促进转运体 2(GLUT2)。此外,在携带 SLCO1B1 常见遗传多态性的肝脏中,GLUT2 的表达显著降低。
我们的研究结果表明,OATP1B 介导的肝甲状腺激素进入是胆固醇和葡萄糖稳态的关键决定因素。